| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0008-6363(97)00229-0 |
| P698 | PubMed publication ID | 9659465 |
| P2093 | author name string | Bobryshev YV | |
| Lord RS | |||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| dendritic cell | Q506253 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 799-810 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions | |
| P478 | volume | 37 |
| Q59742256 | 'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells |
| Q33276712 | Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease |
| Q37866627 | Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets |
| Q36146867 | Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. |
| Q84970651 | Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells |
| Q37857345 | Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque |
| Q55403025 | Atherosclerosis as autoimmune disease. |
| Q42775477 | CD1 expression and the nature of CD1-expressing cells in human atherosclerotic plaques |
| Q73660885 | Can dendritic cells be exploited for therapeutic intervention in atherosclerosis? |
| Q36392394 | Cells of the synovium in rheumatoid arthritis. Dendritic cells. |
| Q41220059 | Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study |
| Q35016970 | Characteristics of immunogenic and tolerogenic dendritic cells within the arterial wall in atherosclerosis and in vitro |
| Q52330706 | Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis. |
| Q37863621 | Chlamydia pneumoniae in foci of "early" calcification of the tunica media in arteriosclerotic arteries: an incidental presence? |
| Q37943057 | Cholesterol, cytokines and diseases. |
| Q73617711 | Colonisation of prosthetic grafts by immunocompetent cells in a sheep model |
| Q37808645 | Current advances in understanding of immunopathology of atherosclerosis |
| Q93158334 | Cytokine Circuits in Cardiovascular Disease |
| Q33916075 | Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ. |
| Q39193752 | Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses |
| Q36009227 | Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis |
| Q82639445 | Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus |
| Q38023274 | Dendritic cells and regulatory T cells in atherosclerosis |
| Q37748449 | Dendritic cells and their role in atherogenesis |
| Q81753352 | Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma |
| Q36108241 | Dendritic cells in atherosclerosis: current status of the problem and clinical relevance |
| Q33651897 | Dendritic cells in atherosclerotic disease |
| Q38218096 | Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects |
| Q37942858 | Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques |
| Q42447144 | Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression withanti-apoptotic Bcl-2 and HSP47 in arterial repair |
| Q39020907 | Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments. |
| Q30656962 | Detection of vascular dendritic cells accumulating calcified deposits in their cytoplasm |
| Q46303746 | Developing dendritic cells become 'lacy' cells packed with fat and glycogen |
| Q35748242 | Disease-associated prion protein in vessel walls |
| Q84383067 | Expression of renin-angiotensin system on dendritic cells of patients with coronary artery disease |
| Q33224310 | Functional role of dendritic cells in patients with unstable angina |
| Q33984920 | Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone. |
| Q38758325 | Generation and labeling of murine bone marrow-derived dendritic cells with Qdot nanocrystals for tracking studies |
| Q34457373 | Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions |
| Q33854081 | Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement |
| Q38076113 | High density lipoproteins and atherosclerosis: emerging aspects. |
| Q33232238 | High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis. |
| Q50930160 | High frequency of contact allergy to gold in patients with endovascular coronary stents. |
| Q33262244 | Human immunodeficiency virus impairs reverse cholesterol transport from macrophages |
| Q42645685 | Hypothesis. Bystanders or bad seeds? Many autoimmune-target cells may be transforming to cancer and signalling "danger" to the immune system |
| Q73501030 | Identification of HIV-1 in the aortic wall of AIDS patients |
| Q73855171 | Identification of dendritic cells in ePTFE grafts explanted from humans |
| Q30983486 | Immunohistochemical and ultrastructural evidence that dendritic cells infiltrate stenotic aortocoronary saphenous vein bypass grafts |
| Q57132246 | Immunological aspects of atherosclerosis: Figure 1 |
| Q73593140 | Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions |
| Q39676934 | Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. |
| Q38083555 | Inflammation and immune system interactions in atherosclerosis |
| Q51447815 | Intracellular localization of oxidized low-density lipoproteins in atherosclerotic plaque cells revealed by electron microscopy combined with laser capture microdissection. |
| Q37608487 | Lipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease |
| Q38371352 | Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes |
| Q63915886 | Macrophages and Cardiovascular Health |
| Q35862512 | Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture |
| Q37139934 | Molecular imaging of atherosclerosis |
| Q48637910 | Nomenclature and contact allergy to nickel and gold. |
| Q35789037 | Novel expression of vascular cell adhesion molecule-1 (CD106) by squamous epithelium in experimental acute graft-versus-host disease |
| Q36154953 | PPARalpha in atherosclerosis and inflammation |
| Q42504018 | Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation |
| Q37998021 | Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta |
| Q38239650 | Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation |
| Q36586196 | Potential role of dendritic cells for progression of atherosclerotic lesions |
| Q36426875 | Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis. |
| Q58905662 | Pro- and Anti-Inflammatory Cytokine Networks in Atherosclerosis |
| Q36427699 | Role of dendritic cells in atherosclerosis |
| Q41332123 | Role of dendritic cells in cardiovascular diseases |
| Q46745779 | S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. |
| Q33773451 | Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation. |
| Q35188689 | Stimulatory interactions between human coronary smooth muscle cells and dendritic cells |
| Q87354605 | Tanshinone II A inhibits dendritic cell-mediated adaptive immunity: potential role in anti-atherosclerotic activity |
| Q35550211 | The autoimmune concept of atherosclerosis |
| Q33998354 | The effect of cyclic mechanical strain on activation of dendritic cells cultured on adhesive substrates |
| Q34107547 | The good smooth muscle cells in atherosclerosis |
| Q39230390 | The immunology of atherosclerosis |
| Q33924531 | The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. |
| Q38229874 | The role of heat shock proteins in atherosclerosis |
| Q37050929 | The role of the vascular dendritic cell network in atherosclerosis |
| Q28081051 | Tolerization against atherosclerosis using heat shock protein 60 |
| Q36762628 | Toll-like receptor 4 in atherosclerosis |
| Q43263819 | Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. |
| Q58785093 | Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation |
| Q73342673 | Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm |
| Q35954820 | oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21 |
Search more.